255 related articles for article (PubMed ID: 22525982)
1. Skeletal health in adult patients with classic galactosemia.
Batey LA; Welt CK; Rohr F; Wessel A; Anastasoaie V; Feldman HA; Guo CY; Rubio-Gozalbo E; Berry G; Gordon CM
Osteoporos Int; 2013 Feb; 24(2):501-9. PubMed ID: 22525982
[TBL] [Abstract][Full Text] [Related]
2. Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism.
Lee JH; Kim JH; Hong AR; Kim SW; Shin CS
Osteoporos Int; 2017 May; 28(5):1667-1674. PubMed ID: 28175978
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone.
Bojesen A; Birkebæk N; Kristensen K; Heickendorff L; Mosekilde L; Christiansen JS; Gravholt CH
Osteoporos Int; 2011 May; 22(5):1441-50. PubMed ID: 20658127
[TBL] [Abstract][Full Text] [Related]
4. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
5. Positive Correlations Between Free Vitamin D and Bone Variables in a Group of Young Lebanese Women.
Alwan A; Rizkallah M; Maalouf G; Matta J; Frenn F; Barakat A; Bachour F; Sebaaly A; Berro AJ; Al Rassy N; Howayek M; Zouhal H; El Hage R
J Clin Densitom; 2018; 21(3):446-452. PubMed ID: 29678393
[TBL] [Abstract][Full Text] [Related]
6. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.
Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M
Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643
[TBL] [Abstract][Full Text] [Related]
7. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.
Arends S; Spoorenberg A; Bruyn GA; Houtman PM; Leijsma MK; Kallenberg CG; Brouwer E; van der Veer E
Osteoporos Int; 2011 May; 22(5):1431-9. PubMed ID: 20603707
[TBL] [Abstract][Full Text] [Related]
8. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort.
Rubin LA; Hawker GA; Peltekova VD; Fielding LJ; Ridout R; Cole DE
J Bone Miner Res; 1999 Apr; 14(4):633-43. PubMed ID: 10234586
[TBL] [Abstract][Full Text] [Related]
9. Determinants of bone density in healthy older men with low testosterone levels.
Kenny AM; Prestwood KM; Marcello KM; Raisz LG
J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):M492-7. PubMed ID: 10995046
[TBL] [Abstract][Full Text] [Related]
10. Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.
Malluche HH; Monier-Faugere MC; Blomquist G; Davenport DL
Osteoporos Int; 2018 Jan; 29(1):125-134. PubMed ID: 28993865
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
Ghannam NN; Hammami MM; Bakheet SM; Khan BA
Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
[TBL] [Abstract][Full Text] [Related]
12. Bone material strength is associated with areal BMD but not with prevalent fractures in older women.
Rudäng R; Zoulakis M; Sundh D; Brisby H; Diez-Perez A; Johansson L; Mellström D; Darelid A; Lorentzon M
Osteoporos Int; 2016 Apr; 27(4):1585-1592. PubMed ID: 26630975
[TBL] [Abstract][Full Text] [Related]
13. SHBG levels are associated with bone loss and vertebral fractures in patients with prostate cancer.
Varsavsky M; Reyes-García R; García-Martín A; González-Ramírez AR; Avilés-Perez MD; Muñoz-Torres M
Osteoporos Int; 2013 Feb; 24(2):713-9. PubMed ID: 22588185
[TBL] [Abstract][Full Text] [Related]
14. Bone Mineral Density across the Lifespan in Patients with Type 1 Diabetes.
Halper-Stromberg E; Gallo T; Champakanath A; Taki I; Rewers M; Snell-Bergeon J; Frohnert BI; Shah VN
J Clin Endocrinol Metab; 2020 Mar; 105(3):746-53. PubMed ID: 31676897
[TBL] [Abstract][Full Text] [Related]
15. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.
Rossini M; Zanotti R; Bonadonna P; Artuso A; Caruso B; Schena D; Vecchiato D; Bonifacio M; Viapiana O; Gatti D; Senna G; Riccio A; Passalacqua G; Pizzolo G; Adami S
Bone; 2011 Oct; 49(4):880-5. PubMed ID: 21782049
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease is associated with low BMD at the hip but not at the spine.
Bezerra de Carvalho KS; Vasco RFV; Custodio MR; Jorgetti V; Moysés RMA; Elias RM
Osteoporos Int; 2019 May; 30(5):1015-1023. PubMed ID: 30693381
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.
Marciniak C; Gabet J; Lee J; Ma M; Brander K; Wysocki N
Osteoporos Int; 2016 Apr; 27(4):1477-1484. PubMed ID: 26576540
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for low bone mineral density in pediatric inflammatory bowel disease: the positive role of physical activity.
Nobile S; Grand RJ; Pappa HM
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):471-476. PubMed ID: 29438136
[TBL] [Abstract][Full Text] [Related]
20. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]